BNP/CALL/MERCK & CO./120/0.1/17.01.25 Share Price

Warrant

DE000PE89AK7

Market Closed - Deutsche Boerse AG 20:50:31 04/07/2024 BST
1.1 EUR -2.65% Intraday chart for BNP/CALL/MERCK & CO./120/0.1/17.01.25
Current month-11.29%
1 month-21.43%
Date Price Change
04/07/24 1.1 -2.65%
03/07/24 1.13 -13.08%
02/07/24 1.3 -2.99%
01/07/24 1.34 +8.06%
28/06/24 1.24 -15.65%

Delayed Quote Deutsche Boerse AG

Last update July 04, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE89AK
ISINDE000PE89AK7
Date issued 16/02/2023
Strike 120 $
Maturity 17/01/2025 (197 Days)
Parity 10 : 1
Emission price 0.92
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.83
Lowest since issue 0.28
Delta0.68x
Omega 7.117
Premium4.93x
Gearing10.44x
Moneyness 1.049
Difference Strike -5.85 $
Difference Strike %-4.88%
Spread 0.03
Spread %2.65%
Intrinsic value 0.5411

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus